{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-245614","form_type":"8-K","ticker":"TEVA","cik":"0000818686","company_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","filed_at":"2023-09-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.723644+00:00","generated_at":"2026-06-10T07:57:18.733063+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Teva appoints Christine Fox as EVP U.S. Commercial; Sven Dethlefs departing Nov 17","bullets":["Sven Dethlefs, EVP North America Commercial, to leave Teva on November 17, 2023 after 15 years.","Christine Fox appointed EVP U.S. Commercial; previously Global President, Gene Therapies at Novartis.","Fox brings 30+ years industry experience from Novartis, Amgen, Merck, Takeda.","CEO Richard Francis thanked Dethlefs and expressed confidence in Fox's ability to lead U.S. business."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-245614","json":"https://secwatch.observer/filing/0001193125-23-245614.json","markdown":"https://secwatch.observer/filing/0001193125-23-245614.md","text":"https://secwatch.observer/filing/0001193125-23-245614.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/818686/000119312523245614/0001193125-23-245614-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/818686/000119312523245614/d469125d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T07:57:18.733063+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9fd5958379","claim":"Sven Dethlefs departed as Executive Vice President, North America Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD.","evidence_excerpt":"Dr. Sven Dethlefs, Executive Vice President, North America Commercial, will be leaving Teva.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/818686/000119312523245614/0001193125-23-245614-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"leaving"},{"label":"Role","value":"Executive Vice President, North America Commercial"}],"fact_type":"executive_change"},{"claim_id":"f0da357a68","claim":"Christine Fox was appointed as Executive Vice President, U.S. Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD.","evidence_excerpt":"Ms. Christine Fox will be appointed as Executive Vice President, U.S. Commercial.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/818686/000119312523245614/0001193125-23-245614-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President, U.S. Commercial"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}